1 Institute of Brain and Behavior, Department of Psychiatry, University of Maastricht, Maastricht, The Netherlands 2 Department of Radiology, Academisch Ziekenhuis Maastricht, Maastricht, The ...

1 Department of Neurology, Westmead Hospital and Western Clinical School, University of Sydney, Sydney, Australia 2 Prince of Wales Medical Research Institute and Prince of Wales Clinical School, ...

Correspondence to: Dr Peter Henningsen, Department of Psychosomatic Medicine, University Hospital, Thibautstr 2, 69115 Heidelberg, Germany; peter_henningsen{at}med.uni-heidelberg.de Objective: To ...

Correspondence to Dr Laura McWhirter, Centre for Clinical Brain Sciences, The University of Edinburgh, Edinburgh EH16 4SB, UK; laura.mcwhirter{at}ed.ac.uk Background The term ‘brain fog’ is ...

Objective: Parkinson’s disease (PD) is a progressive neurological disorder characterised by a large number of motor and non-motor features that can impact on function to a variable degree. This review ...

Movement disorders arise from the complex interplay of multiple changes to neural circuits. Successful treatments for these disorders could interact with these complex changes in myriad ways, and as a ...

2 Department of Medicine (Genetics Program), Boston University School of Medicine, Boston, MA, USA 3 Department of Neurology, Boston University School of Medicine, Boston, MA, USA 4 Department of ...

The brain is in a constant state of dynamic change, for example switching between cognitive and behavioural tasks, and between wakefulness and sleep. The brains of people with epilepsy have additional ...

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder affecting the upper and lower motor neurons. A key clinical feature of ALS is the absence of accurate, early-stage ...

Correspondence to Dr Laura McWhirter, Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh EH8 9YL, UK; laura.mcwhirter{at}ed.ac.uk Performance validity tests (PVTs) are widely used ...

Objective To evaluate the efficacy and safety of intramuscular ultra-high-dose methylcobalamin in patients with amyotrophic lateral sclerosis (ALS). Methods 373 patients with ALS (El Escorial definite ...

Much has been achieved in terms of understanding the complex clinical and genetic heterogeneity of Charcot-Marie-Tooth neuropathy (CMT). Since the identification of mutations in the first CMT ...